James L. Januzzi

Dr. Januzzi is the Chair of Prevencio's Scientific & Clinical Advisory Board and is the company’s Principal Investigator for the Casablanca trial, a senior staff cardiologist at Massachusetts General Hospital, and the Hutter Family Professor of Medicine at Harvard Medical School. He has extensive experience with cardiac biomarker testing, including troponins, inflammatory markers, and novel tests such as ST2, galectin-3, GDF-15, and natriuretic peptides.

Dr. Januzzi has served as Chair or Vice-Chair of numerous consensus and policy documents regarding biomarker testing and has contributed to clinical practice guidelines for heart failure. He is widely published with more than 750 peer-reviewed manuscripts, reviews, and chapters, as well as five textbooks. He serves as an Associate Editor at JACC and JACC Heart Failure, and Guest Editor in Chief at JACC Cardio-Oncology and JACC Case Reports.

Dr. Januzzi is an active and experienced cardiology clinician, with a large clinical practice focused on heart failure and coronary artery disease. He is a Trustee of the American College of Cardiology and has also served as a cardiovascular disease consultant to the Boston Red Sox baseball club since 2005.